230 related articles for article (PubMed ID: 18594526)
21. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
22. Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.
Li J; Luo M; Wang Y; Shang B; Dong L
Oncol Rep; 2016 Sep; 36(3):1345-52. PubMed ID: 27430377
[TBL] [Abstract][Full Text] [Related]
23. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF‑β signaling.
Lu H; Ye J; Zhang L; Li M; Lu S; Yang D; Hu W
Mol Med Rep; 2019 Nov; 20(5):4533-4539. PubMed ID: 31702018
[TBL] [Abstract][Full Text] [Related]
25. Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
Jang SY; Choi SH; Kikkawa D; Lee EJ; Yoon JS
PLoS One; 2021; 16(8):e0255344. PubMed ID: 34383782
[TBL] [Abstract][Full Text] [Related]
26. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma.
Koikawa K; Ohuchida K; Ando Y; Kibe S; Nakayama H; Takesue S; Endo S; Abe T; Okumura T; Iwamoto C; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Nagai E; Mizumoto K; Hashizume M; Nakamura M
Cancer Lett; 2018 Jul; 425():65-77. PubMed ID: 29580808
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
28. Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.
Shams I; Rohmann E; Eswarakumar VP; Lew ED; Yuzawa S; Wollnik B; Schlessinger J; Lax I
Mol Cell Biol; 2007 Oct; 27(19):6903-12. PubMed ID: 17682060
[TBL] [Abstract][Full Text] [Related]
29. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Potential for FGFR Inhibitors in SOX9-FGFR2 Coexpressing Pancreatic Cancer.
OʼSullivan H; Kelleher FC; Lavelle M; McGovern B; Murphy J; Swan N; McDermott R
Pancreas; 2017 Sep; 46(8):e67-e69. PubMed ID: 28796141
[No Abstract] [Full Text] [Related]
31. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
[TBL] [Abstract][Full Text] [Related]
32. A Sox9/Fgf feed-forward loop maintains pancreatic organ identity.
Seymour PA; Shih HP; Patel NA; Freude KK; Xie R; Lim CJ; Sander M
Development; 2012 Sep; 139(18):3363-72. PubMed ID: 22874919
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
34. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
[TBL] [Abstract][Full Text] [Related]
35. Keratinocyte growth factor binding to fibroblast growth factor receptor 2-IIIb promotes epithelial ovarian cancer cell proliferation and invasion.
Wu J; Han W; Yang W; Liu H; Li C; Guo L; Jin Y; Zhang R; Chen H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S347-S353. PubMed ID: 29970688
[TBL] [Abstract][Full Text] [Related]
36. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
[TBL] [Abstract][Full Text] [Related]
37. Potential involvement of Fgf10/Fgfr2 and androgen receptor (AR) in renal fibrosis in adult male rat offspring subjected to prenatal exposure to di-n-butyl phthalate (DBP).
Sun WL; Zhu YP; Ni XS; Jing DD; Yao YT; Ding W; Liu ZH; Ding GX; Jiang JT
Toxicol Lett; 2018 Jan; 282():37-42. PubMed ID: 28919491
[TBL] [Abstract][Full Text] [Related]
38. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
39. Reduced Fgf10/Fgfr2 and androgen receptor (AR) in anorectal malformations male rats induced by di-n-butyl phthalate (DBP): A study on the local and systemic toxicology of DBP.
Jiang JT; Xu HL; Zhu YP; Wood K; Li EH; Sun WL; Yuan Q; Xu DL; Liu ZH; Zhao W; Xia SJ
Toxicology; 2015 Dec; 338():77-85. PubMed ID: 26514922
[TBL] [Abstract][Full Text] [Related]
40. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
Huang T; Wang L; Liu D; Li P; Xiong H; Zhuang L; Sun L; Yuan X; Qiu H
Int J Oncol; 2017 May; 50(5):1501-1512. PubMed ID: 28339036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]